Electroporation of embryonic stem cells for generating transgenic mice and studying in vitro differentiation.
Department of Molecular Immunology, Merck Research Laboratories, Rahway, NJ, USA.
J S
JS
Mudgett
T J
TJ
Livelli
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001755:Blastocyst; D002454:Cell Differentiation; D002934:Cinnamates; D002999:Clone Cells; D004247:DNA / Q000235:genetics / Q000302:isolation & purification; D004351:Drug Resistance / Q000235:genetics; D018274:Electroporation / Q000379:methods*; D004622:Embryo, Mammalian; D005260:Female; D005819:Genetic Markers; D006921:Hygromycin B / Q000031:analogs & derivatives / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D018345:Mice, Knockout / Q000235:genetics; D008822:Mice, Transgenic / Q000235:genetics*; D016685:Mitomycin / Q000494:pharmacology; D009355:Neomycin / Q000494:pharmacology; D013234:Stem Cells / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D014162:Transfection
D000900:Anti-Bacterial Agents; D002934:Cinnamates; D005819:Genetic Markers; D006921:Hygromycin B; C026273:hygromycin A; D016685:Mitomycin; D004247:DNA; D009355:Neomycin